Honeysuckle extracts as a potential inhibitor of SARS-CoV-2 infection

Honeysuckle extracts as a potential inhibitor of SARS-CoV-2 infection

BackgroundIn the current era of coronavirus disease 2019 (COVID-19), we were interested in searching for medications other than the currently available antiviral drugs Paxlovid and Molnupiravir that cause minimal side effects and do not harm the human body. Honeysuckle extract (HSE) is a traditional...

Full description

Saved in:
Bibliographic Details
Main Authors: Ping-Chang Lin, Ying-Ray Lee, Li-Teh Liu, Shyh-Shin Chiou, Po-Chih Chen, Ching-Yi Tsai, Jih-Jin Tsai
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Pharmacology
Subjects:
honeysuckle
Lonicera japonica Thunb.
SARS-CoV-2
COVID-19
extracts
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1517585/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items